Align decisions across the product lifecycle with a shared clinical foundation

In a rapidly changing industry, life sciences and pharma organizations know how essential it is that their innovations and strategic decisions align with evolving evidence and real-world practice. Decisions that don’t reflect real-world clinical practice or aren’t grounded in defensible evidence can delay development and positioning decisions.

UpToDate® provides a single, trusted interpretation of clinical evidence that can be used across medical, commercial, and market access teams. It helps reduce fragmented internal synthesis, enabling fast, consistent, and objective communication. And now UpToDate® Expert AI helps teams reach evidence-based guidance even faster.

With UpToDate, life sciences organizations can tap into the same expert-reviewed clinical evidence that informs confident decision-making for more than 3 million healthcare professionals at more than 50,000 organizations worldwide. UpToDate is used at least once daily by 91% of healthcare professionals.1 By providing efficient access to trusted, evidence-based clinical and medication content that helps multiple departments manage complex decisions and identify opportunities, UpToDate helps align and empower sales operations, market planning, and competitive strategy.

Contact Us
Book A Consultation
Lab worker looking in microscope at work

Why should life sciences and pharma organizations choose UpToDate?

UpToDate offers valuable insights for key initiatives, ranging from clinical trials and pharmacovigilance efforts, to commercialization and market access:

  • Expertise from global healthcare experts across 25 specialties, all in one place
  • More than 13,000 clinical topics
  • More than 8,000 unique drug entries
  • 93% of users say UpToDate gives them confidence in their decision-making
Male health tech worker on computer in a lab.
What is decision latency?
When new evidence emerges or standards of care start to shift, life sciences teams may lose valuable time moving strategies forward while reconciling delayed signals and inconsistent interpretations. A shared approach to clinical interpretation can help accelerate alignment around evidence-based decisions.
Download the eBook

82% of life sciences customers say UpToDate helps their organization make better decisions.2

Aligning data to drive success in life sciences organizations

UpToDate Enterprise Suite aligns the latest drug and clinical intelligence across multiple solutions, helping healthcare organizations fill data gaps, enhance workflow efficiency, and improve collaboration and trust. When disparate life sciences teams are unified through these aligned solutions, it fosters standardization of best practices, streamlined integrations, and a commitment to innovation.

Learn how centralizing resources can transform your processes and unlock potential by exploring our whitepaper.
Download the Whitepaper

The value and impact of clinical data on business decisions

UpToDate is a trusted global partner throughout the healthcare ecosystem, relied upon for helping organizations improve operational effectiveness and ROI. Our suite of solutions delivers an impressive breadth of quality topics that has led to consistent recognition from organizations like KLAS, Frost & Sullivan, U.S. News & World Report, and Healthgrades.

Learn how businesses are combining our consistent clinical and drug data and implementing it across departments and key projects for success.
Download The eBook

How can UpToDate clinical intelligence help accelerate and align decision-making across your life sciences organization?

meeting-three-people-basic

Research and development

  • Review current clinical best practices and treatment regimens from the perspective of practicing clinicians, who are leaders in the topic being discussed.
  • Quickly access the underlying evidence, including care guidelines and research studies that are used to develop best practices and recommendations.
  • Enhance selection when identifying pretrial participants with insight into disease/condition presentation and current treatments.

health-pills-basic

Medical affairs and pharmacovigilance

  • Research epidemiology and treatment standards for diseases.
  • Evaluate the sustainability of drugs for testing based on mechanism of action.
  • Consult evidence to inform clinical trials.
  • Research adverse reactions to understand which are related to specific therapies.
  • Learn about conditions for which certain treatments and protocols are indicated and why.
  • Enhance effectiveness and timeliness of internal training and communications around drugs and treatments.
  • Improve resource allocation and identify opportunities to fill gaps.

screen-idea-basic

Market intelligence and commercialization

  • Derive insights from UpToDate drug topics, which go beyond basic drug information to deliver unique clinical perspective.
  • Understand how experimental drugs may fit into existing treatment paradigms.
  • Provide in-depth drug and clinical information to support sales training.
  • Track competitor drugs, including off-label uses supported by clinicians and the medical literature, to better position current drugs in development.
  • Maintain a constant understanding of competitive pricing and strategize post-approval pricing, promotion, and distribution of products.
  • Understand trends to support effective tailoring of offerings to consumer needs.

health-laptop-basic

Market access and health economics

  • Conduct health economic evaluations to demonstrate the cost-effectiveness of therapies.
  • Inform direct communications with healthcare professionals and subject matter experts to demonstrate clinical effectiveness of products.

“UpToDate is helping us develop better products.”

– Clinical Pharmacologist

Expertly curated information to enhance research and strategic goals

UpToDate for Life Sciences covers 25+ specialties and has 8,000+ unique drug entries, as well as clinical insights and pricing data. This evidence-based, expertly curated information can enhance research, advance formulary development, inform clinical trials, and support discovery and strategic goals.

Learn more about our content development editorial process and its power to keep the latest evidence in workflow and at the fingertips of users throughout your organization.

Read more
Read More About The UpToDate Editorial Process

Are you ready to align key decisions with real-world clinical practice?

Discover how you can help align decision-making across your pharma or life sciences teams with consistent clinical interpretations that reflect real-world practice. Schedule a demo of UpToDate for Life Sciences today.

  • See a tailored demo for your organization.
  • Learn how UpToDate and UpToDate Expert AI can help connect product development, marketing, commercialization, and field teams to expert-reviewed, evidence-based clinical content used by healthcare professionals in practice.
  • Get answers from solution and industry experts. Discuss implementation, integrations, pricing, and best practices for using UpToDate across your teams’ workflows.
  1. NPS survey of 260 healthcare providers (MDs, Residents,, APPs) conducted Apr 2-12, 2024.
  2. UpToDate life sciences customer survey. November 2021. n=70.
Back To Top